尿検査の世界市場予測(~2026年):製品別(ディップスティック、妊娠・受胎能力キット、試薬、使い捨て式、自動型、半自動型、POC分析装置)、用途別(UTI、糖尿病、腎臓病)、エンドユーザー別(病院、ラボ、在宅医療)、検査種類別

【英語タイトル】Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Homecare) & Test Type - Global Forecast to 2026

MarketsandMarketsが出版した調査資料()・商品コード:
・発行会社(調査会社):MarketsandMarkets
・発行日:2021年8月17日
・ページ数:237
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥658,350見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥884,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,083,950見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
マーケッツアンドマーケッツ社は尿検査の世界市場規模が2021年35億ドルから2026年49億ドルまで、年平均7.2%成長すると予想しています。本市場調査資料では、世界の尿検査市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(消耗品、機器)分析、検査種類別(妊娠・受胎能力検査、生化学的尿検査、堆積物尿検査)分析、用途別(疾患スクリーニング、妊娠・受胎能力)分析、エンドユーザー別(診断研究所、病院・クリニック、在宅医療、研究所・研究機関)分析、地域別分析、競争状況、企業情報など、以下の構成でまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・尿検査の世界市場規模:製品別(消耗品、機器)
・尿検査の世界市場規模:検査種類別(妊娠・受胎能力検査、生化学的尿検査、堆積物尿検査)
・尿検査の世界市場規模:用途別(疾患スクリーニング、妊娠・受胎能力)
・尿検査の世界市場規模:エンドユーザー別(診断研究所、病院・クリニック、在宅医療、研究所・研究機関)
・尿検査の世界市場規模:地域別
・競争状況
・企業情報
❖ レポートの概要 ❖

“The global urinalysis market size is projected to reach USD 4.9billion by 2026 from USD 3.5billion in 2021, at a CAGR of 7.2% during the forecast period.”
Market growth is driven by factors such as increasing burden of UTIs, diabetes, and kidney & liver diseases, rising geriatric population and the subsequent increase in age- associated diseases and increasing adoption of POC diagnostic tests. On the other hand, availability of refurbished urine analyzersis expected to limit market growth to a certain extent in the coming years.

“The consumablesaccounted for the highest growth rate in theurinalysismarket, byproduct, during the forecast period.”
The urinalysis market is segmented into consumables and instruments. The consumables segment accounted for the highest growth rate in the urinalysis market in 2020. The requirement of consumables in large numbers compared to instrumentsis the main factor contributing to this segment’s high growth rate. This segment’s market growth can also be attributed to repeat purchases of consumables compared to instruments.

“Disease screening segment accounted for the highest CAGR”
Based on the application, the urinalysis market is segmented into disease screening and pregnancy & fertility. In 2020, the disease screening segment accounted for the highest CAGR.The increasing incidence of UTIs and kidney ailments worldwide are driving the growth of this market.

“Diagnostic Laboratoriessegment accounted for the highest CAGR”
Based on end-users, the urinalysismarket is segmented into diagnostic laboratories, hospitals and clinics, home care settings and research laboratories & institutes. In 2020, the diagnostic laboratories segment accounted for the highest CAGR. This can be attributed to rapidly growing aging population, the increasing global incidence of kidney diseases and UTIs, increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced urinalysis devices such as integrated devices.

“Asia Pacific: The fastest-growing regionurinalysismarket”
The global urinalysismarket is segmented into North America, Europe, Asia Pacific, and Rest of the World. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such rising geriatric population, high burden of chronic diseases such as CKD, growing per capita income, increasing investments in the healthcare industry by key market players, expansion of private-sector hospitals to rural areas in various APAC countries, an increasing number of hospitals and clinics, and the presence of high-growth markets are driving the growth of the urinalysismarket in this region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 40%, Tier 2 – 30%,and Tier 3 -30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America -51%, Europe – 21%, Asia Pacific – 18%, and Rest of the World – 10%

Lits of Companies Profiled in the Report:
• Siemens Healthineers AG (Germany)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Cardinal Health, Inc. (US)
• Abbott Laboratories (US)
• Danaher Corporation (US)
• Sysmex Corporation (Japan)
• Thermo Fisher Scientific Inc. (US)
• QuidelCorporation(US)
• Bio-Rad Laboratories, Inc. (US)
• Becton, Dickinson and Company (US)
• EKF Diagnostics (UK)
• ARKRAY, Inc. (Japan)
• ACON Laboratories, Inc. (US)
• 77 ElektronikaKft. (Hungary)
• URIT Medical Electronic Group Co., Ltd. (China)
• Dirui Industrial Co., Ltd. (China)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• BIOBASE Group (China)
• ERBA Mannheim (UK)
• AlphatechScientitfic (Peru)
• Teco Diagnostics (US)
• Analyticon Technologies AG (Germany)
• Bioway Biological Technology Co. Ltd. (China)
• High Technology Inc. (US)
• Agappe Diagnostics Ltd. (India)

Research Coverage:
This report provides a detailed picture of the global urinalysismarket. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, application, end user, and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall urinalysismarket and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

❖ レポートの目次 ❖

1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 32
1.2.2 MARKETS COVERED 33
FIGURE 1 URINALYSIS MARKET SEGMENTATION 33
1.2.3 YEARS CONSIDERED FOR THE STUDY 34
1.3 CURRENCY 34
1.4 LIMITATIONS 34
1.5 STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
2.2 RESEARCH APPROACH 37
FIGURE 2 URINALYSIS MARKET: RESEARCH DESIGN 37
2.2.1 SECONDARY DATA 38
2.2.1.1 Key data from secondary sources 38
2.2.2 PRIMARY DATA 39
2.2.2.1 Key data from primary sources 39
2.2.2.2 Key industry insights 40
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 41
2.3 MARKET SIZE ESTIMATION 41
2.3.1 BOTTOM-UP APPROACH 41
2.3.1.1 Approach 1: Company revenue estimation approach 42
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 42
2.3.1.2 Approach 2: Market estimation from the parent market 42
FIGURE 5 BOTTOM-UP APPROACH: MARKET ESTIMATION FROM THE PARENT MARKET 42
2.3.1.3 Approach 3: Presentations of companies and primary interviews 43
2.3.1.4 Growth rate assumptions 43
2.3.1.5 CAGR projections 43
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
2.3.2 TOP-DOWN APPROACH 44
FIGURE 7 URINALYSIS MARKET: TOP-DOWN APPROACH 44
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 8 DATA TRIANGULATION METHODOLOGY 45
2.5 ASSUMPTIONS FOR THE STUDY 45
2.6 RISK ASSESSMENT 46
TABLE 1 RISK ASSESSMENT: INFECTIOUS DISEASE DIAGNOSTICS MARKET 46
2.7 COVID-19 HEALTH ASSESSMENT 46
2.8 COVID-19 ECONOMIC ASSESSMENT 46
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 46
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 47
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 48
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE URINALYSIS MARKET 49
3 EXECUTIVE SUMMARY 50
FIGURE 11 URINALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 50
FIGURE 12 URINALYSIS MARKET, BY TEST TYPE, 2021 VS. 2026 (USD MILLION) 51
FIGURE 13 URINALYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 51
FIGURE 14 URINALYSIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 52
FIGURE 15 URINALYSIS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION) 52
4 PREMIUM INSIGHTS 54
4.1 URINALYSIS MARKET OVERVIEW 54
FIGURE 16 THE RISING ADOPTION OF POC DIAGNOSTICS IS A KEY FACTOR EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD 54
4.2 URINALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 55
FIGURE 17 CONSUMABLES SEGMENT TO COMMAND THE LARGEST SHARE OF THE MARKET, BY PRODUCT, IN 2021 55
4.3 URINALYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 55
FIGURE 18 DISEASE SCREENING TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD 55
4.4 URINALYSIS MARKET, BY REGION, 2021 VS. 2026 56
FIGURE 19 NORTH AMERICA TO DOMINATE THE MARKET IN 2021 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 20 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Increasing burden of UTIs, diabetes, and liver & kidney diseases 58
5.2.1.2 Rising geriatric population and the subsequent increase in age-associated diseases 58
TABLE 2 ESTIMATED INCREASE IN THE GERIATRIC POPULATION
BY REGION (2019-2050) 59
5.2.1.3 Increasing adoption of POC urine diagnostic tests 59
5.2.2 RESTRAINTS 60
5.2.2.1 Availability of refurbished urine analyzers 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Emerging economies 60
5.2.3.2 Technological advancements in urine analyzers 60
5.2.4 CHALLENGES 61
5.2.4.1 Changing regulatory landscape for the urinalysis market 61
5.3 IMPACT OF COVID-19 ON THE URINALYSIS MARKET 61
5.4 REALISTIC, PESSIMISTIC, AND OPTIMISTIC SCENARIOS 62
5.4.1 URINALYSIS MARKET 62
FIGURE 21 REALISTIC SCENARIO 62
FIGURE 22 PESSIMISTIC SCENARIO 63
FIGURE 23 OPTIMISTIC SCENARIO 63
5.5 PRICING ANALYSIS 64
TABLE 3 PRICE OF URINALYSIS PRODUCTS (2021) 64
5.6 PATENT ANALYSIS 65
5.6.1 PATENT ANALYSIS OF URINALYSIS PRODUCTS 65
5.6.2 PATENT ANALYSIS OF DIPSTICKS 66
5.7 TRADE ANALYSIS 66
5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS 66
5.7.1.1 Import data for diagnostic and laboratory reagents, by country, 2016─2020 (USD Million) 66
5.7.1.2 Import data for diagnostic and laboratory reagents, by country, 2016─2020 (Tons) 67
5.8 VALUE CHAIN ANALYSIS 67
FIGURE 24 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE 67
FIGURE 25 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 69
5.9 ECOSYSTEM ANALYSIS OF THE URINALYSIS MARKET 69
FIGURE 26 URINALYSIS MARKET: ECOSYSTEM ANALYSIS 69
5.9.1 ROLE IN ECOSYSTEM 70
5.10 PORTER’S FIVE FORCES ANALYSIS 70
TABLE 4 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 70
5.10.1 THREAT OF NEW ENTRANTS 70
5.10.2 THREAT OF SUBSTITUTES 71
5.10.3 BARGAINING POWER OF BUYERS 71
5.10.4 BARGAINING POWER OF SUPPLIERS 71
5.10.5 DEGREE OF COMPETITION 71
5.11 REGULATORY LANDSCAPE 71
5.11.1 NORTH AMERICA 71
5.11.1.1 US 71
5.11.1.2 Canada 72
5.11.2 EUROPE 72
5.11.3 ASIA PACIFIC 72
5.11.3.1 China 72
5.11.3.2 Japan 72
5.11.3.3 India 72
5.11.4 LATIN AMERICA 73
5.11.4.1 Brazil 73
5.11.4.2 MEXICO 73
5.11.5 MIDDLE EAST 73
5.11.6 AFRICA 74
5.12 TECHNOLOGY ANALYSIS 74
5.13 PESTLE ANALYSIS 75
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 76
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR URINALYSIS
PRODUCT MANUFACTURERS 76
5.14.2 REVENUE SHIFT FOR THE URINALYSIS MARKET 76
6 URINALYSIS MARKET, BY PRODUCT 77
6.1 INTRODUCTION 78
TABLE 5 URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 78
TABLE 6 URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 78
6.2 CONSUMABLES 78
6.2.1 PRIMARY NOTES 79
6.2.1.1 Key industry insights 79
TABLE 7 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION) 79
TABLE 8 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2020–2026 (USD MILLION) 79
TABLE 9 URINALYSIS CONSUMABLES MARKET, BY REGION,
2016–2019 (USD MILLION) 80
TABLE 10 URINALYSIS CONSUMABLES MARKET, BY REGION,
2020–2026 (USD MILLION) 80
6.2.2 PREGNANCY & FERTILITY KITS 80
6.2.2.1 Need for rapid pregnancy testing to drive the growth of this market 80
TABLE 11 URINALYSIS PREGNANCY & FERTILITY KITS MARKET, BY REGION,
2016–2019 (USD MILLION) 81
TABLE 12 URINALYSIS PREGNANCY & FERTILITY KITS MARKET, BY REGION,
2020–2026 (USD MILLION) 81
6.2.3 DIPSTICKS 81
6.2.3.1 Dipsticks are used regularly owing to low costs and standard efficiency 81
TABLE 13 URINALYSIS DIPSTICKS MARKET, BY REGION, 2016–2019 (USD MILLION) 82
TABLE 14 URINALYSIS DIPSTICKS MARKET, BY REGION, 2020–2026 (USD MILLION) 82
6.2.4 DISPOSABLES 82
6.2.4.1 The wide usage of urine collection cups will drive the market demand for disposables 82
TABLE 15 URINALYSIS DISPOSABLES MARKET, BY REGION,
2016–2019 (USD MILLION) 83
TABLE 16 URINALYSIS DISPOSABLES MARKET, BY REGION,
2020–2026 (USD MILLION) 83
6.2.5 REAGENTS 83
6.2.5.1 Increasing use of controls & calibrators to drive the market
growth for reagents 83
TABLE 17 URINALYSIS REAGENTS MARKET, BY REGION, 2016–2019 (USD MILLION) 84
TABLE 18 URINALYSIS REAGENTS MARKET, BY REGION, 2020–2026 (USD MILLION) 84
6.3 INSTRUMENTS 84
TABLE 19 KEY PRODUCTS IN THE INSTRUMENTS MARKET 85
TABLE 20 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 85
TABLE 21 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 85
TABLE 22 URINALYSIS INSTRUMENTS MARKET, BY REGION,
2016–2019 (USD MILLION) 85
TABLE 23 URINALYSIS INSTRUMENTS MARKET, BY REGION,
2020–2026 (USD MILLION) 86
6.3.1 AUTOMATED URINE ANALYZERS 86
6.3.1.1 Increasing need for automation for shorter turnaround times to drive the market growth for automated urine analyzers 86
TABLE 24 AUTOMATED URINE ANALYZERS MARKET, BY TYPE,
2016–2019 (USD MILLION) 86
TABLE 25 AUTOMATED URINE ANALYZERS MARKET, BY TYPE,
2020–2026 (USD MILLION) 87
TABLE 26 AUTOMATED URINE ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 87
TABLE 27 AUTOMATED URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 87
6.3.1.2 Integrated urine analyzers 88
6.3.1.2.1 The higher workload in hospitals and laboratories to drive the adoption of integrated urine analyzers 88
TABLE 28 INTEGRATED URINE ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 88
TABLE 29 INTEGRATED URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 88
6.3.1.3 Sediment urine analyzers 89
6.3.1.3.1 Automated sediment urine analyzers increase the productivity of laboratories and integrate patient data for easy access 89
TABLE 30 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2016–2019 (USD MILLION) 89
TABLE 31 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2026 (USD MILLION) 89
TABLE 32 SEDIMENT URINE ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 90
TABLE 33 SEDIMENT URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 90
6.3.1.3.2 Microscopy analyzers 90
6.3.1.3.2.1 Increased adoption of automated microscopy analyzers to drive the market growth of this segment 90
TABLE 34 MICROSCOPY ANALYZERS MARKET, BY REGION, 2016–2019 (USD MILLION) 91
TABLE 35 MICROSCOPY ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION) 91
6.3.1.3.3 Flow cytometry analyzers 91
6.3.1.3.3.1 Accuracy and sensitivity of flow cytometry technique to drive the adoption of these analyzers 91
TABLE 36 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 92
TABLE 37 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 92
6.3.1.4 Biochemical urine analyzers 92
6.3.1.4.1 Increasing incidence of kidney diseases & UTIs to increase the adoption of automated biochemical analyzers 92
TABLE 38 AUTOMATED BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 93
TABLE 39 AUTOMATED BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 93
6.3.2 SEMI-AUTOMATED URINE ANALYZERS 93
6.3.2.1 Semi-automated urine analyzers are used extensively in hospitals & clinics due to lower costs and practical efficiency 93
TABLE 40 SEMI-AUTOMATED ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 94
TABLE 41 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 94
6.3.3 POINT-OF-CARE URINE ANALYZERS 94
6.3.3.1 The need for rapid testing to drive the demand for
POC urine analyzers 94
TABLE 42 POINT-OF-CARE URINE ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 95
TABLE 43 POINT-OF-CARE URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 95
7 URINALYSIS MARKET, BY TEST TYPE 96
7.1 INTRODUCTION 97
TABLE 44 URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 97
TABLE 45 URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 97
7.2 PREGNANCY & FERTILITY TESTS 97
7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE THE GROWTH OF THIS SEGMENT 97
TABLE 46 PREGNANCY & FERTILITY TESTS MARKET, BY REGION,
2016–2019 (USD MILLION) 98
TABLE 47 PREGNANCY & FERTILITY TESTS MARKET, BY REGION,
2020–2026 (USD MILLION) 98
7.3 BIOCHEMICAL URINALYSIS 98
TABLE 48 BIOCHEMICAL URINALYSIS MARKET, BY TYPE, 2016–2019 (USD MILLION) 99
TABLE 49 BIOCHEMICAL URINALYSIS MARKET, BY TYPE, 2020–2026 (USD MILLION) 99
TABLE 50 BIOCHEMICAL URINALYSIS MARKET, BY REGION,
2016–2019 (USD MILLION) 99
TABLE 51 BIOCHEMICAL URINALYSIS MARKET, BY REGION,
2020–2026 (USD MILLION) 100
7.3.1 LABORATORY TESTS 100
7.3.1.1 Laboratory tests use automated or semi-automated analyzers 100
TABLE 52 BIOCHEMICAL URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2016–2019 (USD MILLION) 100
TABLE 53 BIOCHEMICAL URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2020–2026 (USD MILLION) 101
7.3.2 POC TESTS 101
7.3.2.1 The convenience of POC testing drives the growth of this segment 101
TABLE 54 BIOCHEMICAL URINALYSIS MARKET FOR POC TESTS, BY REGION,
2016–2019 (USD MILLION) 101
TABLE 55 BIOCHEMICAL URINALYSIS MARKET FOR POC TESTS, BY REGION,
2020–2026 (USD MILLION) 102
7.4 SEDIMENT URINALYSIS 102
7.4.1 THE INCREASING ADOPTION OF AUTOMATED ANALYZERS TO DRIVE THE GROWTH OF THIS SEGMENT 102
TABLE 56 SEDIMENT URINALYSIS MARKET, BY REGION, 2016–2019 (USD MILLION) 102
TABLE 57 SEDIMENT URINALYSIS MARKET, BY REGION, 2020–2026 (USD MILLION) 103
8 URINALYSIS MARKET, BY APPLICATION 104
8.1 INTRODUCTION 105
TABLE 58 URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 105
TABLE 59 URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 105
8.2 DISEASE SCREENING 105
TABLE 60 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE,
2016–2019 (USD MILLION) 106
TABLE 61 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE,
2020–2026 (USD MILLION) 106
TABLE 62 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION,
2016–2019 (USD MILLION) 106
TABLE 63 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION,
2020–2026 (USD MILLION) 107
8.2.1 URINARY TRACT INFECTIONS 107
8.2.1.1 Increasing prevalence of UTIs to drive the growth of this application segment 107
TABLE 64 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION,
2016–2019 (USD MILLION) 107
TABLE 65 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION,
2020–2026 (USD MILLION) 108
8.2.2 KIDNEY DISEASES 108
8.2.2.1 Rapidly growing geriatric population and the subsequent increase in the prevalence of kidney diseases to drive the market growth 108
TABLE 66 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION,
2016–2019 (USD MILLION) 109
TABLE 67 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION,
2020–2026 (USD MILLION) 109
8.2.3 DIABETES 109
8.2.3.1 Development of advanced analytical tools for diabetes
to drive the market growth 109
TABLE 68 URINALYSIS MARKET FOR DIABETES, BY REGION,
2016–2019 (USD MILLION) 110
TABLE 69 URINALYSIS MARKET FOR DIABETES, BY REGION,
2020–2026 (USD MILLION) 110
8.2.4 LIVER DISEASES 110
8.2.4.1 The high prevalence of liver diseases increases the demand for urinalysis testing 110
TABLE 70 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION,
2016–2019 (USD MILLION) 111
TABLE 71 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION,
2020–2026 (USD MILLION) 111
8.2.5 OTHER DISEASE SCREENING APPLICATIONS 111
TABLE 72 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS,
BY REGION, 2016–2019 (USD MILLION) 112
TABLE 73 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS,
BY REGION, 2020–2026 (USD MILLION) 112
8.3 PREGNANCY AND FERTILITY 112
8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 112
TABLE 74 URINALYSIS MARKET FOR PREGNANCY AND FERTILITY, BY REGION,
2016–2019 (USD MILLION) 113
TABLE 75 URINALYSIS MARKET FOR PREGNANCY AND FERTILITY, BY REGION,
2020–2026 (USD MILLION) 113
9 URINALYSIS MARKET, BY END USER 114
9.1 INTRODUCTION 115
TABLE 76 URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 115
TABLE 77 URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 115
TABLE 78 URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION) 116
TABLE 79 URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION) 116
TABLE 80 URINALYSIS END USER MARKET, BY TEST TYPE, 2018 (USD MILLION) 117
9.2 DIAGNOSTIC LABORATORIES 117
9.2.1 INCREASING OUTSOURCING OF DIAGNOSTIC TESTS TO LABORATORIES FOR REDUCED COSTS DRIVES THE MARKET GROWTH 117
TABLE 81 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION,
2016–2019 (USD MILLION) 117
TABLE 82 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION,
2020–2026 (USD MILLION) 118
9.3 HOSPITALS AND CLINICS 118
9.3.1 THE INCREASING ADOPTION OF DIAGNOSTIC TOOLS FOR URINALYSIS TESTING TO DRIVE THE MARKET GROWTH FOR THIS END-USER SEGMENT 118
TABLE 83 URINALYSIS MARKET FOR HOSPITALS AND CLINICS, BY REGION,
2016–2019 (USD MILLION) 119
TABLE 84 URINALYSIS MARKET FOR HOSPITALS AND CLINICS, BY REGION,
2020–2026 (USD MILLION) 119

9.4 HOME CARE SETTINGS 119
9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO DRIVE THE GROWTH OF THIS MARKET 119
TABLE 85 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION,
2016–2019 (USD MILLION) 120
TABLE 86 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION,
2020–2026 (USD MILLION) 120
9.5 RESEARCH LABORATORIES & INSTITUTES 120
9.5.1 GROWING FOCUS ON DEVELOPING INNOVATIVE TESTS FOR DISEASE DETECTION TO DRIVE THE MARKET GROWTH 120
TABLE 87 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES,
BY REGION, 2016–2019 (USD MILLION) 121
TABLE 88 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES,
BY REGION, 2020–2026 (USD MILLION) 121
10 URINALYSIS MARKET, BY REGION 122
10.1 INTRODUCTION 123
TABLE 89 URINALYSIS MARKET, BY REGION, 2016–2019 (USD MILLION) 123
TABLE 90 URINALYSIS MARKET, BY REGION, 2020–2026 (USD MILLION) 123
10.2 NORTH AMERICA 123
FIGURE 27 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT 124
TABLE 91 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 124
TABLE 92 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 125
TABLE 93 NORTH AMERICA: URINALYSIS MARKET, BY END USER,
2016–2019 (USD MILLION) 125
TABLE 94 NORTH AMERICA: URINALYSIS MARKET, BY END USER,
2020–2026 (USD MILLION) 125
TABLE 95 NORTH AMERICA: URINALYSIS END USER MARKET, BY PRODUCT,
2018 (USD MILLION) 126
TABLE 96 NORTH AMERICA: URINALYSIS END USER MARKET, BY APPLICATION,
2018 (USD MILLION) 126
10.2.1 US 126
10.2.1.1 The US dominated the North American urinalysis market in 2020 126
TABLE 97 US: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 127
TABLE 98 US: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 127
TABLE 99 US: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 128
TABLE 100 US: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 128
TABLE 101 US: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 128
TABLE 102 US: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 128
TABLE 103 US: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 129
TABLE 104 US: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 129
10.2.2 CANADA 129
10.2.2.1 The increasing prevalence of chronic conditions like liver diseases in Canada drives the market growth 129
TABLE 105 CANADA: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 130
TABLE 106 CANADA: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 130
TABLE 107 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 130
TABLE 108 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 131
TABLE 109 CANADA: URINALYSIS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 131
TABLE 110 CANADA: URINALYSIS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 131
TABLE 111 CANADA: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 131
TABLE 112 CANADA: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 132
10.3 EUROPE 132
TABLE 113 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 133
TABLE 114 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 133
TABLE 115 EUROPE: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 133
TABLE 116 EUROPE: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 134
TABLE 117 EUROPE: URINALYSIS END USER MARKET, BY PRODUCT,
2018 (USD MILLION) 134
TABLE 118 EUROPE: URINALYSIS END USER MARKET, BY APPLICATION,
2018 (USD MILLION) 135
10.3.1 GERMANY 135
10.3.1.1 Increasing healthcare expenditure to drive the market growth in Germany 135
TABLE 119 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 136
TABLE 120 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 136
TABLE 121 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 136
TABLE 122 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 136
TABLE 123 GERMANY: URINALYSIS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 137
TABLE 124 GERMANY: URINALYSIS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 137
TABLE 125 GERMANY: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 137
TABLE 126 GERMANY: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 138
10.3.2 UK 138
10.3.2.1 Rising government healthcare expenditure propels market
growth in the UK 138
TABLE 127 UK: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 139
TABLE 128 UK: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 139
TABLE 129 UK: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 139
TABLE 130 UK: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 139
TABLE 131 UK: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 140
TABLE 132 UK: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 140
TABLE 133 UK: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 140
TABLE 134 UK: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 140
10.3.3 FRANCE 141
10.3.3.1 Rising R&D expenditure in France to drive the market growth 141
TABLE 135 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 141
TABLE 136 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 141
TABLE 137 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 142
TABLE 138 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 142
TABLE 139 FRANCE: URINALYSIS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 142
TABLE 140 FRANCE: URINALYSIS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 142
TABLE 141 FRANCE: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 143
TABLE 142 FRANCE: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 143
10.3.4 ITALY 143
10.3.4.1 Age-related chronic kidney disease owing to a large senior population in Italy to drive the market growth for urinalysis 143
TABLE 143 ITALY: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 144
TABLE 144 ITALY: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 144
TABLE 145 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 144
TABLE 146 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 144
TABLE 147 ITALY: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 145
TABLE 148 ITALY: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 145
TABLE 149 ITALY: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 145
TABLE 150 ITALY: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 145
10.3.5 SPAIN 146
10.3.5.1 The rising geriatric population in Spain is expected to drive the market growth 146
TABLE 151 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 146
TABLE 152 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 146
TABLE 153 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 146
TABLE 154 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 147
TABLE 155 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 147
TABLE 156 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 147
TABLE 157 SPAIN: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 147
TABLE 158 SPAIN: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 148
10.3.6 REST OF EUROPE 148
TABLE 159 ROE: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 148
TABLE 160 ROE: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 149
TABLE 161 ROE: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 149
TABLE 162 ROE: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 149
TABLE 163 ROE: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 149
TABLE 164 ROE: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 150
TABLE 165 ROE: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 150
TABLE 166 ROE: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 150

10.4 ASIA PACIFIC 151
FIGURE 28 APAC: URINALYSIS MARKET SNAPSHOT 152
TABLE 167 APAC: URINALYSIS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 153
TABLE 168 APAC: URINALYSIS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 153
TABLE 169 APAC: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 153
TABLE 170 APAC: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 154
TABLE 171 APAC: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION) 154
TABLE 172 APAC: URINALYSIS END USER MARKET, BY APPLICATION,
2018 (USD MILLION) 155
10.4.1 CHINA 155
10.4.1.1 Improving healthcare infrastructure in China supports the growth of the urinalysis market 155
TABLE 173 CHINA: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 156
TABLE 174 CHINA: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 156
TABLE 175 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 157
TABLE 176 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 157
TABLE 177 CHINA: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 157
TABLE 178 CHINA: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 157
TABLE 179 CHINA: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 158
TABLE 180 CHINA: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 158
10.4.2 INDIA 158
10.4.2.1 Increasing private & public investments in India’s healthcare system to drive the market growth for urinalysis testing 158
TABLE 181 INDIA: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 159
TABLE 182 INDIA: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 159
TABLE 183 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 159
TABLE 184 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 159
TABLE 185 INDIA: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 160
TABLE 186 INDIA: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 160
TABLE 187 INDIA: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 160
TABLE 188 INDIA: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 160
10.4.3 JAPAN 161
10.4.3.1 Favorable regulatory framework to drive the market growth in Japan 161
TABLE 189 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 161
TABLE 190 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 161
TABLE 191 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 162
TABLE 192 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 162
TABLE 193 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 162
TABLE 194 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 162
TABLE 195 JAPAN: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 163
TABLE 196 JAPAN: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 163
10.4.4 REST OF ASIA PACIFIC 163
TABLE 197 ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 164
TABLE 198 ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 164
TABLE 199 ROAPAC: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 164
TABLE 200 ROAPAC: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 164
TABLE 201 ROAPAC: URINALYSIS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 165
TABLE 202 ROAPAC: URINALYSIS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 165
TABLE 203 ROAPAC: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 165
TABLE 204 ROAPAC: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 165
10.5 REST OF THE WORLD 166
10.5.1 INCREASING GOVERNMENT INITIATIVES TO IMPROVE THE HEALTHCARE INFRASTRUCTURE IN THE REGION TO DRIVE THE MARKET GROWTH FOR URINALYSIS PRODUCTS 166
TABLE 205 ROW: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 167
TABLE 206 ROW: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 167
TABLE 207 ROW: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION) 167
TABLE 208 ROW: URINALYSIS END USER MARKET, BY APPLICATION,
2018 (USD MILLION) 168
11 COMPETITIVE LANDSCAPE 169
11.1 OVERVIEW 169
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 169
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN
THE URINALYSIS MARKET 169
TABLE 209 OVERVIEW OF STRATEGIES DEPLOYED BY KEY URINALYSIS PRODUCT MANUFACTURING COMPANIES 169
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 170
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN
THE URINALYSIS MARKET 171
11.4 MARKET SHARE ANALYSIS 171
FIGURE 30 URINALYSIS MARKET SHARE, BY KEY PLAYER (2020) 172
TABLE 210 URINALYSIS MARKET: DEGREE OF COMPETITION 172
11.4.1 URINALYSIS MARKET RANKING, BY TEST TYPE 173
11.4.1.1 Biochemical urinalysis 173
TABLE 211 GLOBAL BIOCHEMICAL URINALYSIS MARKET, BY KEY PLAYERS, 2020 173
11.4.1.2 Sediment urinalysis 174
TABLE 212 GLOBAL SEDIMENT URINALYSIS MARKET, BY KEY PLAYERS, 2020 174
11.4.1.3 Pregnancy & fertility tests 174
TABLE 213 GLOBAL PREGNANCY & FERTILITY TESTS MARKET, BY KEY PLAYERS, 2020 174
11.5 COMPANY EVALUATION QUADRANT 174
11.5.1 LIST OF EVALUATED VENDORS 174
11.5.2 STARS 174
11.5.3 EMERGING LEADERS 174
11.5.4 PERVASIVE PLAYERS 175
11.5.5 PARTICIPANTS 175
FIGURE 31 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 175
11.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020) 176
11.6.1 PROGRESSIVE COMPANIES 176
11.6.2 STARTING BLOCKS 176
11.6.3 RESPONSIVE COMPANIES 176
11.6.4 DYNAMIC COMPANIES 176
FIGURE 32 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020 177
11.7 COMPETITIVE BENCHMARKING 177
FIGURE 33 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE URINALYSIS MARKET 177
TABLE 214 COMPANY PRODUCT TYPE FOOTPRINT 178
TABLE 215 COMPANY GEOGRAPHICAL FOOTPRINT 178
11.8 COMPETITIVE SCENARIO 178
11.8.1 PRODUCT LAUNCHES AND REGULATORY APPROVALS 178
TABLE 216 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS 178
11.8.2 DEALS 179
TABLE 217 KEY DEALS 179
11.8.3 URINALYSIS: OTHER DEVELOPMENTS 179
TABLE 218 OTHER KEY DEVELOPMENTS 179
12 COMPANY PROFILES 180
12.1 KEY PLAYERS 180
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win,
Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 SIEMENS HEALTHINEERS AG 180
TABLE 219 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 180
FIGURE 34 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020) 181
12.1.2 F. HOFFMANN-LA ROCHE 184
TABLE 220 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW 184
FIGURE 35 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020) 185
12.1.3 CARDINAL HEALTH, INC. 187
TABLE 221 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 187
FIGURE 36 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2020) 188
12.1.4 ABBOTT LABORATORIES 191
TABLE 222 ABBOTT LABORATORIES: BUSINESS OVERVIEW 191
FIGURE 37 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020) 192
12.1.5 DANAHER CORPORATION 195
TABLE 223 DANAHER CORPORATION: BUSINESS OVERVIEW 195
FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 196
12.1.6 SYSMEX CORPORATION 198
TABLE 224 SYSMEX CORPORATION: BUSINESS OVERVIEW 198
FIGURE 39 SYSMEX CORPORATION: COMPANY SNAPSHOT (2020) 199
12.1.7 THERMO FISHER SCIENTIFIC INC. 201
TABLE 225 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 201
FIGURE 40 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020) 202
12.1.8 QUIDEL CORPORATION 204
TABLE 226 QUIDEL CORPORATION: BUSINESS OVERVIEW 204
FIGURE 41 QUIDEL CORPORATION: COMPANY SNAPSHOT (2020) 205
12.1.9 BECTON, DICKINSON AND COMPANY 207
TABLE 227 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 207
FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 208
12.1.10 BIO-RAD LABORATORIES 210
TABLE 228 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 210
FIGURE 43 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2020) 211
12.1.11 EKF DIAGNOSTICS 213
TABLE 229 EKF DIAGNOSTICS: BUSINESS OVERVIEW 213
FIGURE 44 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2020) 214
12.2 OTHER PLAYERS 215
12.2.1 ARKRAY, INC. 215
12.2.2 ACON LABORATORIES, INC. 217
12.2.3 77 ELEKTRONIKA KFT. 219
12.2.4 URIT MEDICAL ELECTRONIC GROUP CO., LTD. 221
12.2.5 DIRUI INDUSTRIAL CO., LTD. 222
12.2.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 224
12.2.7 BIOBASE GROUP 225
12.2.8 ERBA MANNHEIM 226
12.2.9 ALPHATECH SCIENTIFIC 227
12.2.10 TECO DIAGNOSTICS 228
12.2.11 ANALYTICON BIOTECHNOLOGIES AG 229
12.2.12 BIOWAY BIOTECHNOLOGY 230
12.2.13 HIGH TECHNOLOGY INC. 231
12.2.14 AGAPPE DIAGNOSTICS LTD. 232
12.2.15 GENRUI BIOTECH INC. 233
12.2.16 SPINREACT S.A. 233
12.2.17 DIALAB GMBH 233
12.2.18 QUANTIMETRIX CORPORATION 234
12.2.19 BIOCARE CORPORATION 234
12.2.20 RANDOX LABORATORIES LTD. 234
12.2.21 PZ CORMAY SA 235
12.2.22 YD DIAGNOSTICS 235
12.2.23 CONTEC MEDICAL SYSTEMS CO., LTD. 235
12.2.24 RAYTO LIFE AND ANALYTICAL SCIENCES CO., LTD. 236
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 237
13.1 INSIGHTS FROM INDUSTRY EXPERTS 237
13.2 DISCUSSION GUIDE 238
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 240
13.4 AVAILABLE CUSTOMIZATIONS 242
13.5 RELATED REPORTS 242
13.6 AUTHOR DETAILS 243



★調査レポート[尿検査の世界市場予測(~2026年):製品別(ディップスティック、妊娠・受胎能力キット、試薬、使い捨て式、自動型、半自動型、POC分析装置)、用途別(UTI、糖尿病、腎臓病)、エンドユーザー別(病院、ラボ、在宅医療)、検査種類別] (コード:)販売に関する免責事項を必ずご確認ください。
★調査レポート[尿検査の世界市場予測(~2026年):製品別(ディップスティック、妊娠・受胎能力キット、試薬、使い捨て式、自動型、半自動型、POC分析装置)、用途別(UTI、糖尿病、腎臓病)、エンドユーザー別(病院、ラボ、在宅医療)、検査種類別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆